Olfactory Bulbs in Arthritis Model Mouse Persistently Express Interleukin-6 before the Onset of Arthritis: Relationship to Food Intake

Neuroimmunomodulation. 2023;30(1):277-290. doi: 10.1159/000534249. Epub 2023 Sep 28.

Abstract

Introduction: Rheumatoid arthritis (RA) can be comorbid with psychiatric symptoms. Brain abnormalities in RA patients and in arthritis models have been reported. However, it remains unclear when these abnormalities occur and where they are distributed. In this study, we analyzed spatiotemporal changes in gene expression in the brains of mice with collagen-induced arthritis (CIA).

Methods: Mice were divided into three groups: (i) CIA (all mice developed arthritis on day 35): complete Freund's adjuvant (CFA) and type II collagen at initial immunization, and incomplete Freund's adjuvant (IFA) and type II collagen at booster immunization; (ii) C(+/-) (50% mice developed arthritis on day 35): only IFA at booster immunization; and (iii) C(-/-) (no arthritis): only CFA at initial immunization and only IFA at booster immunization. Whole brains were collected at ten stages of arthritis and divided into six sections. Real-time polymerase chain reaction was performed using RNA extracted from the brain, and the expression of proinflammatory cytokines and glial markers was semi-quantified. Arthritis score, body weight, and food and water intakes were recorded and analyzed for correlations with brain gene expression. We also investigated the effect of interleukin-6 (IL-6) injection in the olfactory bulbs (OBs) on the food intake.

Results: After booster immunization, a transient increase in Integrin subunit α-M and IL-1β was observed in multiple areas in CIA. IL-6 is persistently expressed in the OB before the onset of arthritis, which is correlated with body weight loss and decreased food intake. This change in the OB was observed in the C(+/-) but not in the C(-/-) groups. In the C(+/-) group, non-arthritic mice showed the same changes in the OB as the arthritic mice. This elevation in IL-6 levels persisted throughout the chronic phase until day 84. In addition, IL-6 injection into the OB reduced food intake.

Conclusion: Persistent elevation of IL-6 in the OB from the early stage of arthritis may be an important finding that might explain the neuropsychiatric pathophysiology of RA, including appetite loss, which is present in the early stages of the disease and manifests as a variety of symptoms over time.

Keywords: Arthritis; Food intake; Interleukin-6; Olfactory bulb.

MeSH terms

  • Animals
  • Arthritis, Experimental*
  • Arthritis, Rheumatoid*
  • Collagen Type II / metabolism
  • Eating
  • Interleukin-6* / metabolism
  • Mice
  • Olfactory Bulb* / metabolism

Substances

  • Collagen Type II
  • Interleukin-6

Grants and funding

This study was supported by JSPS KAKENHI (Grant No. 21K16296). This grant was used for data acquisition, English editing service, and submission cost. D. K. was partly supported by Eisai Co., Ltd., Chugai Pharmaceutical Co., Ltd., Ayumi Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Eli Lilly Japan K.K., AbbVie GK, Asahi Kasei Pharma Co., and Taisho Pharmaceutical Holdings Co., Ltd. Some consumables were contributed from these research funds.